These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 2033691)
1. The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma. Miller J; Horsfall DJ; Marshall VR; Rao DM; Leong SY J Urol; 1991 Jun; 145(6):1192-6. PubMed ID: 2033691 [TBL] [Abstract][Full Text] [Related]
2. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy. Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039 [TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma. Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459 [TBL] [Abstract][Full Text] [Related]
4. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479 [TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy. Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434 [TBL] [Abstract][Full Text] [Related]
7. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401 [TBL] [Abstract][Full Text] [Related]
8. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure. Borre M; Høyer M; Nerstrøm B; Overgaard J Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024 [TBL] [Abstract][Full Text] [Related]
9. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904 [TBL] [Abstract][Full Text] [Related]
10. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer. Pollack A; Zagars GK; el-Naggar AK; Terry NH Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527 [TBL] [Abstract][Full Text] [Related]
11. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors. Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493 [TBL] [Abstract][Full Text] [Related]
12. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. al-Abadi H; Nagel R J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829 [TBL] [Abstract][Full Text] [Related]
13. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181 [TBL] [Abstract][Full Text] [Related]
14. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer]. Ishikawa A Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320 [TBL] [Abstract][Full Text] [Related]
15. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects. Forsslund G; Nilsson B; Zetterberg A Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis of stage D2 prostatic carcinoma. Yokogi H; Mizutani M; Ishibe T Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707 [TBL] [Abstract][Full Text] [Related]
17. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048 [TBL] [Abstract][Full Text] [Related]
18. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy. Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934 [TBL] [Abstract][Full Text] [Related]
19. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study. al-Abadi H; Nagel R J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]